Application

17242667 · BISPECIFIC ANTI-VEGF/ANG2 ANTIBODY FORMULATION

Filed 2021-04-28 · Granted · Patent 12503503 (2025-12-23) The official file ↗The patent and its PDF ↗ · Art unit 1645 · Examiner Christine J Saoud Typical · CPC A61K 9/08 · Hoffmann-La Roche Inc. · GENENTECH, INC.

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

33.5 mo

to disposition 55.9 mo

Statutes raised

112

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.